CTRI/2023/04/051819招募中Unknown
Effectiveness and impact on quality of life of a combination of trimetazidine with one hemodynamic agent (ß-blocker or Ca-channel blocker), in patients recently diagnosed with stable angina and still symptomatic despite first line hemodynamic therapy: a prospective, international, non-interventional study.
Servier Affaires Médicales0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1 Male and female recently diagnosed symptomatic stable Angina patients is equals to Patients presenting with typical angina or angina equivalent with evidence of myocardial ischaemia ST segment changes on ECG regional myocardial dysfunction at echocardiography regional perfusion defect etc Canadian Cardiovascular Society class II or III as well as patients with angina at rest vasospastic angina
- •2 Age morethan 18 years old or the age of the majority in the concerned country
- •3 Inclusion of patients into this non interventional study is exclusively determined by the decision of the physician regarding medical meaningfulness and rationale of treatment with the combination under evaluation in the study
- •4 Patient already treated by only one first line antianginal haemodynamic agent beta blocker or Calcium channel blocker according to CCS management guidelines 2019 and still symptomatic within two to four weeks after initiation of this antianginal treatment. At inclusion SAQ 7 Angina Frequency score should be lessthan 60
- •5 Patient for whom the physician intends to prescribe trimetazidine based on her or his daily medical practice in the management of symptomatic Angina pectoris respecting the SmPC in force in the country Such treatment decision must be taken independently from the participation of the patient in the study.
- •Evidence of a personally signed and dated informed consent document indicating that the patient or a legally acceptable representative has been informed of all pertinent aspects of the study.
排除标准
- •1 Any contra-indication to trimetazidine according to SmPC hypersensitivity to the active substance or to any of the excipients Parkinson disease parkinsonian symptoms, tremors, restless leg syndrome and other related movement disorders severe renal impairment creatinine clearance lessthan 30ml per min.
- •2 Patients already treated by trimetazidine before entry into the study.
- •3 Patients needing another antianginal treatment than the combination assessed within the study (one hemodynamic agent beta blocker or Calcium channel blocker with one metabolic agent ie trimetazidine.
- •4 Previous and current acute coronary syndrome (including any unstable angina: angina at rest which lasts more than 20 min and crescendo angina).
- •5 Previous coronary revascularization by CABG or PCI for either acute coronary syndrome or stable ischaemic heart disease.
- •6 Presence of heart failure, left ventricular hypertrophy, valve disease, dilated or hypertrophic cardiomyopathy, myocarditis, pericarditis, endocarditis, chronic arrythmias or other cardiac vascular condition requiring pharmacological treatment.
- •7 Presence of symptomatic anemia.
- •8 Planned revascularization.
- •9 Life expectancy lessthan 1 year.
- •10 Pregnancy or intention to become pregnant or lactating women during the study.
研究者
相似试验
尚未招募
4 期
Study to compare the efficacy and impact on quality of life of two types of repetitive transcranial magnetic stimulation in chronic migraine patientsCTRI/2024/03/064293Institute of Medical Sciences Banaras Hindu University
已完成
不适用
Effect of quality of life training on self-efficacy hemodialysis patientsEnd stage renal disease treat with hemodialysis.Care involving dialysisIRCT2013061513677N1Vice chancellor for research, Islamic Azad University Bandar abbas Branch90
进行中（未招募）
1 期
A study of efficacy, safety, and quality of life (QOL) in patients with chronic idiopathic urticaria dosed with Aerius tablets (5 mg, 10 mg or 20 mg once daily). - ACCEchronic idiopathic urticariaMedDRA version: 6.1 Level: PT Classification code 10021247EUCTR2006-001449-33-ITSCHERING-PLOUGH600
撤回
不适用
Effectiveness and efficiency on quality of life of an awarenessprogram on sensory processing Issues for adolescents and adults with autism spectrum disorders and a normal or high IQ.AutismAutism Spectrum DisorderNL-OMON37188niversitair Medisch Centrum Groningen40
招募中
不适用
Application observation on quality of life and cohabitation problems in patients with the suburethral PVDF band DynaMesh®-SIS (soft)N39.3Stress incontinenceDRKS00033888FEG Textiltechnik Forschungs- und Entwicklungsgesellschaft mbH100